PALO ALTO, Calif., Nov. 11, 2025 /PRNewswire/ — Get Well and RhythmX AI, both part of the SymphonyAI Group, have merged to create a unified AI-driven healthcare company. Backed by the multi-billion-dollar SymphonyAI Group and serving 150 health systems, the new entity—led by RhythmX AI Founder and CEO Deepthi Bathina—aims to redefine precision care through an AI-powered, patient-centric platform that enhances outcomes for patients, clinicians, nurses, and health systems.
“For years, I’ve witnessed AI’s power to transform industries,” said Dr. Romesh Wadhwani, Chairman of SymphonyAI Group. “By bringing together RhythmX AI and Get Well, we’ve combined world-class talent, technology, and scale to revolutionize healthcare—aligning AI innovation with deep clinical insight and patient needs. This union empowers health systems to thrive in a new era of patient-centric, AI-driven precision care.”
Guided by a shared vision, the combined company aims to drive transformation where patient engagement, clinical excellence, and financial performance advance together. Its Precision Care AI Platform integrates data from over 10 sources—including clinical, payer, financial, and social datasets—alongside EHRs, policies, and clinical guidelines to generate real-time insights and recommendations that improve outcomes for patients, clinicians, and nurses while enhancing the financial health of care systems.
Built on responsible AI and backed by 25,000+ clinical validations, the platform seamlessly integrates with any EHR and has already produced 300,000+ personalized treatment recommendations. From predicting disease progression and detecting undiagnosed conditions to optimizing coding and billing at the point of care, RhythmX AI unites medical superintelligence with medical economics to elevate care quality and strengthen revenue integrity across health systems.
Get Well brings its leadership in digital patient engagement to the new organization, expanding its mission of empowering patients across care settings. Its solutions help patients better understand, follow, and stay engaged in their care journeys. Serving top U.S. health systems—including Adventist Healthcare, Ascension, UMass Memorial, BayCare, and LifeBridge Health—Get Well has driven measurable impact: over 65% reduction in hospital readmissions, significant new revenue gains, and consistently high patient satisfaction. Building on this foundation, GW RhythmX will amplify these outcomes through advanced AI-powered precision care.
Together, the combined company serves 150+ health systems and has impacted more than 85 million patients, including 8 million U.S. veterans. It stands as the only integrated platform proven to enhance margins, improve quality metrics, and deliver better clinical outcomes at enterprise scale.
Deepthi Bathina, Founder and CEO of RhythmX AI, will lead the combined company as Chief Executive Officer. A visionary healthcare leader with over two decades of experience at the intersection of healthcare, technology, and AI, Bathina has held senior roles at Humana, Nuance Communications, and Wolters Kluwer Health, driving innovations that improved outcomes for 16 million members and scaling AI solutions used by hundreds of thousands of clinicians worldwide.
“With our teams joining forces, we have a rare opportunity to transform how medicine is practiced,” said Bathina. “By orchestrating healthcare’s vast data into a single platform of actionable intelligence, we can help clinicians focus on what matters most—improving patient care, strengthening connections, and unlocking new levels of operational and financial performance for health systems.”
Michael O’Neil, Founder and CEO of Get Well, will serve as Vice Chair of the combined company. “This marks a defining moment for SymphonyAI Group, our companies, and the industry,” said O’Neil. “By merging decades of enterprise AI leadership with Get Well’s proven patient engagement solutions and RhythmX AI’s precision technology, we’re accelerating a better, smarter future for clinicians and the patients they serve.”
About GW RhythmX
GW RhythmX is redefining healthcare through connected, AI-native intelligence that seamlessly integrates clinical insight, patient engagement, and enterprise-wide care coordination. By combining RhythmX AI’s precision care technology with Get Well’s trusted patient engagement expertise, the company enables health systems to deliver the right care, at the right time, through the right clinician and channel.
Its solutions are active across 150+ health systems, reaching over 85 million patients, including 8 million U.S. veterans. The company’s award-winning innovations were recognized in 2024 by KLAS Research, Fierce Healthcare, and AVIA Marketplace.
As part of SymphonyAI Group, GW RhythmX leverages extensive enterprise resources — including over $1 billion in R&D investment, longitudinal data from 300 million patients, 4.4 billion annual claims, and a network of 1.8 million healthcare professionals across 3,000+ facilities worldwide — to advance the next generation of precision, AI-driven healthcare.
About SymphonyAI Group
SymphonyAI Group (SAIGroup) is a global private investment firm dedicated to building leading enterprise AI companies that drive innovation and growth. Its portfolio — including ConcertAI, SymphonyAI, and GW RhythmX — delivers transformative AI solutions that create value for businesses, professionals, and patients across multiple industries.
Together, SAIGroup companies employ over 4,000 engineers, data scientists, and domain experts, all focused on advancing AI-powered transformation. The firm is supported by a $1 billion commitment from its Founder and CEO, Dr. Romesh Wadhwani, a renowned entrepreneur and philanthropist.
Learn more at www.saigroup.ai and follow SAIGroup on LinkedIn
Chris Gale
chris@galestrategies.com
